143 related articles for article (PubMed ID: 16546435)
21. Protoporphyrin IX enhancement by 5-aminolaevulinic acid peptide derivatives and the effect of RNA silencing on intracellular metabolism.
Bourré L; Giuntini F; Eggleston IM; Wilson M; MacRobert AJ
Br J Cancer; 2009 Mar; 100(5):723-31. PubMed ID: 19240715
[TBL] [Abstract][Full Text] [Related]
22. Fluorescence spectroscopy of normal mouse skin exposed to 5-aminolaevulinic acid and red light.
Juzenas P; Iani V; Bagdonas S; Rotomskis R; Moan J
J Photochem Photobiol B; 2001 Aug; 61(1-2):78-86. PubMed ID: 11485851
[TBL] [Abstract][Full Text] [Related]
23. The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid. Implications in cutaneous photodynamic sensitization.
Casas A; Fukuda H; Di Venosa G; Batlle AM
Br J Dermatol; 2000 Sep; 143(3):564-72. PubMed ID: 10971330
[TBL] [Abstract][Full Text] [Related]
24. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
[TBL] [Abstract][Full Text] [Related]
25. Peptide-targeted dendrimeric prodrugs of 5-aminolevulinic acid: A novel approach towards enhanced accumulation of protoporphyrin IX for photodynamic therapy.
Tewari KM; Dondi R; Yaghini E; Pourzand C; MacRobert AJ; Eggleston IM
Bioorg Chem; 2021 Apr; 109():104667. PubMed ID: 33611140
[TBL] [Abstract][Full Text] [Related]
26. Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid.
Fritsch C; Lehmann P; Stahl W; Schulte KW; Blohm E; Lang K; Sies H; Ruzicka T
Br J Cancer; 1999 Mar; 79(9-10):1603-8. PubMed ID: 10188913
[TBL] [Abstract][Full Text] [Related]
27. Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes.
Ortel B; Chen N; Brissette J; Dotto GP; Maytin E; Hasan T
Br J Cancer; 1998 Jun; 77(11):1744-51. PubMed ID: 9667642
[TBL] [Abstract][Full Text] [Related]
28. Novel prodrug approach to photodynamic therapy: Fmoc solid-phase synthesis of a cell permeable peptide incorporating 5-aminolaevulinic acid.
Dixon MJ; Bourré L; MacRobert AJ; Eggleston IM
Bioorg Med Chem Lett; 2007 Aug; 17(16):4518-22. PubMed ID: 17587577
[TBL] [Abstract][Full Text] [Related]
29. Improved peptide prodrugs of 5-ALA for PDT: rationalization of cellular accumulation and protoporphyrin IX production by direct determination of cellular prodrug uptake and prodrug metabolization.
Giuntini F; Bourré L; MacRobert AJ; Wilson M; Eggleston IM
J Med Chem; 2009 Jul; 52(13):4026-37. PubMed ID: 19492812
[TBL] [Abstract][Full Text] [Related]
30. Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies.
Perotti C; Fukuda H; DiVenosa G; MacRobert AJ; Batlle A; Casas A
Br J Cancer; 2004 Apr; 90(8):1660-5. PubMed ID: 15083200
[TBL] [Abstract][Full Text] [Related]
31. Comparation of liposomal formulations of ALA Undecanoyl ester for its use in photodynamic therapy.
Di Venosa G; Hermida L; Fukuda H; Defain MV; Rodriguez L; Mamone L; MacRobert A; Casas A; Batlle A
J Photochem Photobiol B; 2009 Aug; 96(2):152-8. PubMed ID: 19560367
[TBL] [Abstract][Full Text] [Related]
32. Activity of phosphatase-sensitive 5-aminolevulinic acid prodrugs in cancer cell lines.
Herceg V; Lange N; Allémann E; Babič A
J Photochem Photobiol B; 2017 Jun; 171():34-42. PubMed ID: 28472723
[TBL] [Abstract][Full Text] [Related]
33. A key role for the mitochondrial benzodiazepine receptor in cellular photosensitisation with delta-aminolaevulinic acid.
Mesenhöller M; Matthews EK
Eur J Pharmacol; 2000 Oct; 406(2):171-80. PubMed ID: 11020479
[TBL] [Abstract][Full Text] [Related]
34. Photosensitization of pancreatic tumour cells by delta-aminolaevulinic acid esters.
Whitaker CJ; Battah SH; Forsyth MJ; Edwards C; Boyle RW; Matthews EK
Anticancer Drug Des; 2000 Jun; 15(3):161-70. PubMed ID: 11049084
[TBL] [Abstract][Full Text] [Related]
35. Photodynamic therapy: the development of new photosensitisers.
Wainwright M
Anticancer Agents Med Chem; 2008 Apr; 8(3):280-91. PubMed ID: 18393787
[TBL] [Abstract][Full Text] [Related]
36. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment.
Ross EV; Romero R; Kollias N; Crum C; Anderson RR
Br J Dermatol; 1997 Nov; 137(5):736-42. PubMed ID: 9415233
[TBL] [Abstract][Full Text] [Related]
37. The use of dipeptide derivatives of 5-aminolaevulinic acid promotes their entry to tumor cells and improves tumor selectivity of photodynamic therapy.
Di Venosa G; Vallecorsa P; Giuntini F; Mamone L; Batlle A; Vanzuli S; Juarranz A; MacRobert AJ; Eggleston IM; Casas A
Mol Cancer Ther; 2015 Feb; 14(2):440-51. PubMed ID: 25519699
[TBL] [Abstract][Full Text] [Related]
38. delta-Aminolaevulinic acid-induced porphyrin synthesis and photodynamic inactivation of Escherichia coli B.
Szocs K; Gabor F; Csik G; Fidy J
J Photochem Photobiol B; 1999 May; 50(1):8-17. PubMed ID: 10443030
[TBL] [Abstract][Full Text] [Related]
39. Hexyl aminolaevulinate is a more effective topical photosensitiser precursor than methyl aminolaevulinate and 5-aminolaevulinic acids when applied in equimolar doses.
Morrow DI; McCarron PA; Woolfson AD; Juzenas P; Juzeniene A; Iani V; Moan J; Donnelly RF
J Pharm Sci; 2010 Aug; 99(8):3486-98. PubMed ID: 20222026
[TBL] [Abstract][Full Text] [Related]
40. Novel patch-based systems for the localised delivery of ALA-esters.
Morrow DI; McCarron PA; Woolfson AD; Juzenas P; Juzeniene A; Iani V; Moan J; Donnelly RF
J Photochem Photobiol B; 2010 Oct; 101(1):59-69. PubMed ID: 20634088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
